Skip to main content
OpenTrials

Clinical trial condition

Sickle Cell Anemia

Explore clinical trials studying Sickle Cell Anemia. Study availability and eligibility vary by location and protocol.

113 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Sickle Cell Anemia trial results

Completed

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

NCT04134299

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
  • Advanced Pharma CR, LLC Miami, Florida, United States
  • Primary Care research Atlanta, Georgia, United States
  • Newark Beth Israel Medical Center Newark, New Jersey, United States
View Trial Details
Completed

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

NCT00125788

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Kaiser Permanente Bellflower, California, United States
  • Harbor-UCLA Medical Center Torrance, California, United States
  • Grady Memorial Hospital Atlanta, Georgia, United States
  • University of Medicine and Dentistry, New Jersey New Brunswick, New Jersey, United States
View Trial Details
Completed

Losartan to Reverse Sickle Nephropathy

NCT01479439

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • University of Louisville Louisville, Kentucky, United States
  • NHLBI Bethesda, Maryland, United States
  • Akron Children's Hospital Akron, Ohio, United States
View Trial Details
Completed

Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

NCT01783990

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Center for Cancer and Blood Disorders Washington D.C., District of Columbia, United States
  • Howard University College of Medicine Washington D.C., District of Columbia, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

NCT01179217

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Phoenix Children's Hospital Center for Cancer and Blood Disorders Phoenix, Arizona, United States
  • Kaiser Permanente Inglewood, California, United States
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
View all 31 locations
View Trial Details

Related conditions